Celanese (CE) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Management is focused on cash generation, cost reduction, deleveraging, and portfolio optimization, including the announced divestiture of Micromax® and other potential asset sales.
Q1 2025 net sales were $2.39B, down 9% year-over-year but up 1% sequentially, with a net loss of $21M and adjusted EPS of $0.57, exceeding guidance.
Operating profit was $168M, with operating EBITDA of $414M and margins of 7% and 17%, respectively.
Strategic priorities include aggressive self-help actions, operational flexibility, and ongoing deleveraging through refinancing and reduced dividends.
Demand uncertainty and macroeconomic weakness remain key risks, especially in automotive, paints, coatings, and construction end-markets.
Financial highlights
Q1 2025 adjusted EPS was $0.57, above guidance of $0.25–$0.50; free cash flow was ($73M), outperforming the guided ($300M) outflow.
FY 2025 free cash flow is targeted at $700M–$800M, up from $498M in 2024, supported by inventory reduction, lower CapEx, and reduced cash taxes.
Operating EBITDA for 2024 was $2.4B, with a 7% CAGR since 2012.
Net cash provided by operating activities was $37M in Q1 2025; cash and cash equivalents stood at $951M as of March 31, 2025.
Total debt increased to $12.78B from $12.58B at year-end 2024.
Outlook and guidance
Q2 2025 adjusted EPS guidance is $1.30–$1.50, with tailwinds from cost savings, operational improvements, and JV dividend timing.
FY 2025 free cash flow expected to rise 40–60% year-over-year, assuming no major demand downturn.
Management expects demand conditions to remain sluggish in Q2 2025, especially in key end-markets.
Long-term earnings power is seen as strong, with $2 per quarter EPS as an initial target.
Full-year earnings visibility remains limited due to tariff and global trade uncertainties.
Latest events from Celanese
- Sales and operating profit grew, but financing costs and restructuring drove a $253 million loss.CE
Q4 2004 - Pricing and productivity lifted FY 2005 profit, but leverage and input-cost risks persisted.CE
Q4 2005 - Pricing and productivity lifted FY 2006 operating profit 30.3% to $747M.CE
Q4 2006 - Pricing and currency lifted sales 12%, while outages, costs and refinancing weighed on results.CE
Q4 2007 - Recession cut earnings, but cash improved and recovery was expected in 2010.CE
Q4 2009 - Recovery lifted sales and operating profit; 2011 growth was expected across all segments.CE
Q4 2010 - FY11 earnings grew on pricing and mix, while major capacity and ethanol investments set up the next growth phase.CE
Q4 2011 - Acetyl pricing and currency dragged FY12 results; 12%–14% earnings growth targeted for FY13.CE
Q4 2012 - A $742 million relocation gain drove record reported profit amid mixed segment trends.CE
Q4 2013 - Sales and adjusted EPS advanced as record cash flow funded growth and shareholder returns.CE
Q4 2014